Zhou Jie, Chen Ye, Yu Songlin, Wang Hui, Wang Yufeng, Chen Quanning
Department of Hematology, Tongji Hospital of Tongji University, Tongji University School of Medicine.
Department of Gastroenterology, Tongji Hospital of Tongji University, Tongji University School of Medicine.
J Clin Gastroenterol. 2025 Mar 1;59(3):269-275. doi: 10.1097/MCG.0000000000002009.
The aim of this study was to evaluate the efficacy, safety, and surgical outcomes of 2-stage management, namely preoperative endoscopic retrograde cholangiopancreatography (ERCP) + laparoscopic cholecystectomy (ERCP+LC) or LC + postoperative ERCP (LC+ERCP), as well as 1-stage management, LC + laparoscopic common bile duct exploration (LCBDE) for treating patients with gallstones and common bile duct stones (CBDS).
This retrospective study analyzed the data of 180 patients with common bile duct stones (CBDS) who were admitted to the Department of General Surgery at Tongji Hospital, Tongji University, between January 2019 and June 2021. The study included 3 groups: ERCP+LC (group 1), LC+ERCP (group 2), and LC+LCBDE (group 3), each consisting of 60 patients. Clinical metrics of the patients were collected and compared among the groups.
Group 3 had the shortest operation duration and hospital stay compared with group 1 and group 2. In addition, group 3 had the lowest long-term postoperative complications, particularly the recurrence rate of CBDS. The total cost was also the lowest in group 3. Furthermore, patients in group 3 had the lowest postoperative amylase levels. All patients in the study achieved successful stone clearance. There were no significant differences in the conversion to other procedures rate, postoperative alanine aminotransferase (ALT), aspartate aminotransferase (AST), total bilirubin, and mortality among the three groups ( P > 0.05).
Both 1-stage management and 2-stage management are effective treatments for CBDS. The LC+LCBDE management is a safe treatment option, offering shorter hospital stays and operation duration, lower costs, and fewer complications.
本研究旨在评估两阶段治疗方案(即术前内镜逆行胰胆管造影术(ERCP)+腹腔镜胆囊切除术(ERCP+LC)或LC+术后ERCP(LC+ERCP))以及一阶段治疗方案(LC+腹腔镜胆总管探查术(LCBDE))治疗胆囊结石合并胆总管结石(CBDS)患者的疗效、安全性及手术结果。
本回顾性研究分析了2019年1月至2021年6月期间同济大学附属同济医院普通外科收治的180例胆总管结石(CBDS)患者的数据。研究分为3组:ERCP+LC组(第1组)、LC+ERCP组(第2组)和LC+LCBDE组(第3组),每组60例患者。收集患者的临床指标并在组间进行比较。
与第1组和第2组相比,第3组的手术时间最短,住院时间也最短。此外,第3组术后长期并发症最低,尤其是胆总管结石复发率。第3组的总费用也是最低的。此外,第3组患者术后淀粉酶水平最低。本研究所有患者均成功清除结石。三组患者的其他手术转化率、术后丙氨酸氨基转移酶(ALT)、天冬氨酸氨基转移酶(AST)、总胆红素及死亡率无显著差异(P>0.05)。
一阶段治疗方案和两阶段治疗方案都是治疗CBDS的有效方法。LC+LCBDE治疗方案是一种安全的治疗选择,具有住院时间短、手术时间短、费用低及并发症少的优点。